Get started

Earnings

Tesla's $50 Bil Plunge: Navigating Challenges & the Road Ahead In a shocking turn of events, Tesla ( NASDAQ:TSLA ), the world's most valuable electric carmaker, saw its stock plummet by over 12%, wiping out a staggering $50 billion in market capitalization. The nosedive came on the heels of disappointing Q4 earnings, where Tesla ( NASDAQ:TSLA ) reported a 40% decline in earnings per share and warned of potentially lower growth in 2024. CEO Elon Musk attributed the slump to a price war with a Chinese-made rival, impacting the company's bottom line. Challenges and Margin Pressures: Tesla's fourth-quarter earnings fell short of analysts' expectations, with a gross margin of 17.6%, compared to 23.8% a year earlier. Automotive gross margin, a closely watched figure, dropped to 17.2%, reflecting a price war-induced strain. Musk acknowledged the challenges, particularly the pressure on profit margins, and warned that the company does not have a clear picture of how margins will evolve in 2024. Redwood Initiative: In a bid to revitalize growth, Musk announced an ambitious initiative to launch a new mass-market electric vehicle code-named "Redwood" by mid-2025. Described as a compact crossover, this move is crucial for Tesla ( NASDAQ:TSLA ) as it seeks to stay competitive and navigate the evolving landscape of the electric vehicle market. The announcement, however, raised questions about the timeline and potential impact on Tesla's ( NASDAQ:TSLA ) overall strategy. Market Reaction and Investor Sentiment: Unsurprisingly, Tesla's stock experienced a 12% decline, reaching $181.70 in Thursday's market action. With Musk's recent push to increase his stake from 13% to 25%, and his ambitious vision for Tesla ( NASDAQ:TSLA ) to become a leader in AI and robotics, investor sentiment has become a focal point. Musk's demand for more shares and voting power adds another layer of complexity to the company's future trajectory. 2024 Outlook and Uncertainties: As Tesla ( NASDAQ:TSLA ) braces for a year of potential challenges, Musk emphasized the importance of executing key projects such as the next-generation vehicle, energy storage, and full self-driving. However, uncertainties linger, including the impact of ongoing price cuts, supply-demand dynamics in the electric vehicle market, and the evolving regulatory landscape. Conclusion: Tesla's recent financial turbulence underscores the inherent volatility of the electric vehicle sector. The Redwood initiative, though promising, adds an element of uncertainty to the company's future. As Tesla ( NASDAQ:TSLA ) navigates the challenges posed by a price war, shifting profit margins, and the impending launch of Redwood, stakeholders will be closely watching to see how the electric car giant adapts to this pivotal moment in its journey. The unfolding narrative of Tesla ( NASDAQ:TSLA ) in 2024 promises to be a story of resilience, innovation, and strategic decision-making.
NASDAQ:TSLA
by DEXWireNews
Tesla 2023 Review and Outlook2023 Review In 2023, Tesla delivered over 1.2 million Model Y’s establishing it as the best-selling vehicle globally, regardless of type, signaling a remarkable shift in the automotive landscape. Despite initial skepticism about the viability of electric vehicles (EVs), this success has proven otherwise. Maintaining a robust free cash flow of $4.4 billion throughout 2023, they strategically directed significant resources towards future growth projects, resulting in record-high capital expenditures and research and development (R&D) expenses. They remain committed to innovation and expansion. Energy storage deployments soared to 14.7 gigawatt-hours (GWh) in 2023, more than doubling the previous year's figures. Simultaneously, Energy Generation and Storage business witnessed a nearly fourfold increase in profits. The Services & Other business also experienced a substantial transformation, turning a $500 million loss in 2019 into a $500 million profit by 2023. In the final quarter, the cost of goods sold per vehicle exhibited a sequential decline, a testament to the company's dedication to enhancing efficiency. Looking ahead to 2024, Tesla’s focus remains on scaling production, investing in future growth, and uncovering additional cost-saving measures. In a groundbreaking development, December saw the rollout of Version 12 of Full Self-Driving Beta, a system trained on data from a vast fleet of over a million vehicles. This advanced AI-driven system influences various vehicle controls, such as steering wheel, pedals, and indicators, without relying on hard-coded driving behaviors. V12 signifies a significant leap forward in the journey toward achieving full autonomy. The company’s sights are set on introducing the next generation platform expeditiously, with plans to commence production at Gigafactory Texas. This revolutionary platform is poised to redefine the manufacturing process for vehicles, ushering in a new era of automotive innovation. Outlook Volume: The company currently finds itself between two substantial growth phases. The first wave commenced with the global expansion of the Model 3/Y platform, and they anticipate the next surge to be triggered by the worldwide expansion of the next-generation vehicle platform. In 2024, the growth rate of their vehicle volume may experience a notable decrease compared to 2023, primarily due to the focus of the company on the launch of the next-generation vehicle at Gigafactory Texas. During this period, the growth rate of deployments and revenue in the Energy Storage business will surpass that of the Automotive business they announced Cash: They maintain ample liquidity to support the product roadmap, long-term capacity expansion plans, and other financial obligations. Profit: The company persists in implementing innovations to reduce manufacturing and operational costs, while foreseeing a shift in the profit landscape. Over time, they anticipate that profits from hardware-related aspects will be complemented by an acceleration in AI, software, and fleet-based profits. Product: The ramp-up of Cybertruck production and deliveries is slated to progress steadily throughout the year. Concurrently, they continue to make significant strides in the development of our next-generation platform.
NASDAQ:TSLALong
by financialflagship
AMZN solid earnings high volume for 10 months Cup and HandleAMZN has risen lately above the lip of the cup of the pattern on this 4H chart. The pattern suggests $ 50 USD upside or 35% beyond present price. The chart shows the buying coming in once price reached a rounded bottom an began an uptrend. Earnings beats have been significant especially compared with the miss a year ago. AMZN is like the massive river with branches feeding the volume of the river's depth and breadth downstream. Its dominance and resilience is impeccable like others in the titans of tech. Price is now in the ascending bullish continuation portion of the handle. I see this as a setup for a long swing stock trade as AMZN heads into the next earnings. Another long play is call options in five weeks at $ 156 or six months expiration at $176 strike which is the head and shoulders pattern of 2021.
NASDAQ:AMZNLong
by AwesomeAvani
RDFN fintech penny stock pre-earnings LONGOn the RDFN shows the trend up after a massive earnings beat and then the fade down into this past week. Price is presently situated at the 0.5 Fib level of the retracement of that trend up. Time is presently at the 0.38 Fib time zone extending from the trend up. The dual TF RSI shows the lines jumping over the 50 level in the past couple of days. The ADX indicator shows the ADX+ crossing over ADX- with the ADX+ now over the 20 threshold. I see RDFN as set for a pre-earnings momentum trade and will also take call options for the Feb 16 expiration the day after the report ( Striking $8 & 8.5). Of interest, a rate cut may be getting baked into RDFN.
NASDAQ:RDFNLong
by AwesomeAvani
HRTX a biotech penny stock with 70% in two months LONGHRTX has been suggested by various trading websites as a potentially explosive penny biotech stock for 2024. It has experienced excellent price actions since an earnings beat in November. It beat the estimates; that is to say it burned about half as much cash as the analysts estimated the it would. Today it pumped 11%. Relevant articles can be found compiled on the Yahoo Finance page linked here. The chart is 120 minutes. A alpha trend indicator is shown and the supertrend since the November earnings is upward. An AI Lorentzian indicator is added with a 2000 candle lookback to generate buy and sell signals. It calculated a 59% win on 83 trades over those 2000 candles two hours each; this amounts to about 2000 x 2 / 6 hrs per session or more than 600 trading days = 2 1/2 years. Also supporting an entry at this time is the faster (45 min) RSI line rising over the 50 level while the slower ( 240 minutes in red) RSI line has been over the 50 level since those earnings. The ADX indicator had a DI- and DI + flip with a mini pullback to close out last week's trading ( profit taking). The volatility indicator also showed that dip with selling volatility greater than buying which has now flipped. Given that price has went 5X in 2 months , there is a possibility HRTX is overbought. Analysts seem to think otherwise. I will take a stock position here and anticipate holding the position into the next earnings. For trade management I will take partials of 5 % each at the high of day for ten days going into earnings and hold the remaining 50% through the earnings. In the meanwhile I will review the trade if the machine-learning alo indicator generates either a buy or sell signal. For those lacking the risk tolerance for money-losing biotechnology penny stocks with high potential but are aware that biotechnology is expected to be "outperforming" in 2024, XBI and LABU are ETFs with risk-mitigation in the form of a diverse portfolio from the sector.
NASDAQ:HRTXLong
by AwesomeAvani
ASML Surges on Record Orders and EarningsNASDAQ:ASML , the chipmaking equipment giant, witnessed a soaring 10% surge in its stock value following the announcement of its fourth-quarter earnings. The company reported record orders, outstripping analysts' expectations, and achieved a net profit of 2 billion euros ($2.2 billion) with sales reaching 7.2 billion euros ($7.8 billion). While this stellar performance delighted investors, a cloud of uncertainty looms as NASDAQ:ASML cautions about potential impacts on future sales to China due to new export restrictions. Record-Breaking Performance: NASDAQ:ASML 's stellar financial results for the fourth quarter showcased the company's robust performance in the face of a challenging economic landscape. Net profit increased by an impressive 9% from the previous year, reaching 2 billion euros, while sales hit 7.2 billion euros, surpassing analyst estimates. The star of the show was the record-breaking net bookings, soaring to an unprecedented 9.2 billion euros, primarily driven by robust demand for NASDAQ:ASML 's cutting-edge equipment. Dividend Increase: Despite the uncertainty in global markets, NASDAQ:ASML expressed confidence by announcing a dividend for the year of 6.10 euros ($6.65) per ordinary share, signifying a 5.2% increase over the previous year. Shareholders will also receive an interim dividend of 1.45 euros ($1.58) per share in February, underscoring the company's commitment to delivering value to its investors. China Export Concerns: While basking in the glory of its impressive financial performance, NASDAQ:ASML did not shy away from addressing potential challenges ahead. The company warned that future sales to China could face headwinds due to new export restrictions. NASDAQ:ASML anticipates a 10-15% decline in deliveries to China in 2024, signaling a potential impact on its revenue from this critical market. The specifics of the export restrictions remain unclear, but they highlight the growing complexities in the global trade landscape. Investor Response: In response to the mixed signals from NASDAQ:ASML 's earnings report, the stock price soared to $860.04, reflecting a 10.6% increase as of midday on the announcement day. The market's positive reaction indicates investor confidence in NASDAQ:ASML 's ability to navigate challenges and capitalize on the strong demand for its advanced semiconductor manufacturing equipment. Conclusion: NASDAQ:ASML 's remarkable performance in the fourth quarter, marked by record orders and earnings that exceeded expectations, showcases its resilience and dominance in the chipmaking equipment industry. However, the cautionary note about potential challenges in the Chinese market adds an element of uncertainty to the otherwise positive narrative. Investors will closely monitor how NASDAQ:ASML navigates these hurdles and sustains its growth trajectory in an ever-evolving global economic landscape.
NASDAQ:ASMLLong
by DEXWireNews
Freeport-McMoRan's Golden Surge: A Deep Dive into Q4 Earnings Freeport-McMoRan (NYSE: NYSE:FCX ) has recently reported a robust performance in its fourth-quarter earnings, surpassing Wall Street estimates and revealing a 10% increase in gold production for the year 2023. This article explores the key highlights from Freeport's financial report, analyzes the factors contributing to its success, and delves into the company's outlook for the future. Strong Financial Performance: Freeport-McMoRan's Q4 net income of $388 million or $0.27 per share exceeded analysts' expectations, showcasing a resilient performance despite challenging market conditions. The company's adjusted net income of $393 million further underlines its financial strength. Revenue Growth and Production Boost: The company reported a revenue of $5.905 billion for the October to December period, marking a notable increase from the previous year. Freeport attributes this growth to a substantial increase in copper production, with 1.095 billion pounds mined in Q4 2023 compared to 1.070 billion pounds in the same quarter of 2022. Gold Production Surge: Freeport's gold production witnessed a remarkable surge, with 573,000 ounces produced in Q4 2023 compared to 472,000 ounces in the same period of 2022. The annual gold production of 1.993 million ounces in 2023 reflects a strategic focus on diversification and capitalizing on the robust gold market. CEO's Optimistic Outlook: Freeport-McMoRan's ( NYSE:FCX ) CEO, Richard Adkerson, expressed optimism about the company's future, emphasizing a focus on operational excellence and investment plans. Adkerson highlighted the team's success in 2023 and outlined strategic initiatives for 2024, with a commitment to enhancing the long-term value of the company's assets. 2024 Projections and Market Impact: The company projects consistent copper production in 2024 and anticipates further growth in gold. Consolidated sales volumes are expected to reach 4.1 billion pounds of copper and 2.0 million ounces of gold. The positive outlook has contributed to a rally in NYSE:FCX stock, with a 5.9% gain and a breach above key moving averages. Cost Management and Capital Expenditure: Freeport-McMoRan remains committed to cost discipline, projecting an average cost of $1.60 per pound of copper in 2024. Additionally, capital expenditures are expected to decrease to $4.6 billion, reflecting prudent financial management and the nearing completion of the Indonesia smelter. Technical Analysis and Investor Sentiment: NYSE:FCX stock's impressive rally, reaching a 5.9% gain, indicates positive investor sentiment. NYSE:FCX is in a potential bullish trend, with the stock surpassing the converged 50- and 200-day moving averages. The emergence of a handle with a buy point at 43.42 further adds to the intrigue for potential investors. Conclusion: Freeport-McMoRan's ( NYSE:FCX ) stellar Q4 performance, driven by increased copper and gold production, sets the stage for a promising 2024. CEO Richard Adkerson's optimistic outlook, coupled with prudent cost management and strategic initiatives, positions the company for sustained growth. As global economic conditions evolve, Freeport-McMoRan's success becomes not only a testament to its operational excellence but also a beacon for investors seeking opportunities in the mining sector.
NYSE:FCXLong
by DEXWireNews
MMM long play3M had a decent earningsreport, however investors were not happy with the lack luster revnue forecast for 2024. Largest selloff since 2019. This opens up a great potential play. Short term fib retracement to .618, Has potential to keep moving to the downside. However some strong support at 93. And a bottom support of 85. Now for the upside potential. Looking at the current trend, it has a upper resistance from 160's for 2024 long term. Sizing in with potential stops at ~93
NYSE:MMMLong
by galactic_ventures
1
Tesla reporting this week! $TSLATesla will report as soon as this Wednesday, Jan. 24, after the market close. Personally, I don't plan any trading activity here before the report. But at the moment the stock is in a technically interesting zone. I see a double technical pattern here - Inv. Head and Shoulders. Based on the structure of the daily chart, the price is now in a potential right shoulder (RSh) zone, which could be a good area to start a position. Meanwhile, the entire daily structure is a right shoulder (WkRsh) for the weekly pattern, which gives the current price zone more strength. Of course, the report could break the technical pattern, but I will be watching and waiting for one of my triggers to occur.
NASDAQ:TSLALong
by ivanistrading
2
Stocks at New All-Time Highs Ahead of Earnings: CATThis Dow component attempted a new all-time high and failed. However, it has ample support from the prior sideways trend after the previous all-time high. NYSE:CAT has been over-speculated as it moved out of its bottom low. The company reports end of January. Watching to see how the stock performs in the next week or so should indicate whether it will be stuck range bound for another couple of quarters or if it will have the fundamentals to support a new high. For now, it has more of the appearance of a range bound sideways pattern developing. Caterpillar Inc. did well during the years of huge real estate and city development in China. Unfortunately, the great industrial revolution of China is long gone, their population in decline due to fewer births and more deaths reducing their billions. Their consumer-based economy has slammed into Market Saturation as their population continues to age at a faster pace than any nation on earth. CAT needs to find another source for its machinery.
NYSE:CAT
by MarthaStokesCMT-TechniTrader
UEC an energy penny stock pops out of ascending channel LONGUEC is a uranium company somewhat independent of the oil, solar and lithium stocks that dominate the energy sector. Nuclear is touted as green and not contributory to climate change with no carbon impact. It pollution or radioactivity is self-contained and isolated with heavy regulatory safeguards All that said, a few days ago analysts at Eight Capital raised the status of UEC to "strong buy" with a price target of $13 or about 75% above current valuation. Such a high upside is uncommon in the energy sector. The 4H chart shows price broke out from an ascending channel of several months duration with a corresponding relative volume of 4x the running mean. The price action is that of a high tight flag patter n invoking the moderately strong probability of more bullish momentum after a consolidation is completed. I see this as a great long swing trade with earnings coming in two months or call options OTM targeting a strike price of $10 for the mid-March expiration. Given the stock price at present such call options would have about $40 premium per contract. Lastly, the ETFs URA and URNM appear to track the price action of UEC fairly well. If a trader prefers diversification or risk moderation of ETFs these two are reasonable alternatives. Uranium trades do not have geopolitical risk to consider as much as oil and gas yet another reason to give this a further look. .
AMEX:UEC
by AwesomeAvani
1
HD: Finally Patterning Out Post-PandemicNYSE:HD benefited greatly from the pandemic lockdown and the numerous stimulus checks that over-stimulated all nations' economies. The stock has now moved above its trading range and has sustained, aka held onto, those gains. This patterns out the excessive revenues and earnings that were inevitably unsustainable for all of the companies that benefited from the brief surge of revenues due to the "over-stimulus checks." This is the Weekly Chart to show that the Year over Year comparatives that harmed HD for a couple of years is now patterned out.
NYSE:HDLong
by MarthaStokesCMT-TechniTrader
$LRCX approaching gap fill area and is a week away from earningsNASDAQ:LRCX 's recent close above the 9 EMA signals bullish potential. Holding steadily above the $763 level could pivot the stock towards $768, aligning with a crucial gap fill area and setting sights on $778. The positive momentum in related stocks like NASDAQ:NVDA , NASDAQ:AMD , and NASDAQ:SMCI may act as a catalyst for NASDAQ:LRCX , especially given its critical role in memory chip production. Watch for possible significant movements around the January 24 earnings, as these developments could impact its trajectory.
NASDAQ:LRCXLong
by RockyFresh340
1
Symmetrical Triangle for a Long positionUSDCAD opened with Lower high and gave a big bearish candle on first day of the week, I was looking at different time frames and saw a symmetrical pattern on the one minute time frame (Using 15 minute to publish, analysis on 1 minute time frame), though I do not recommend using the one minute time frame at the opening but it was a sure bullish move that was coming. Took the trade with a small stop loss and TP at the size of the length of the triangle base, just above the slope of lower high and made a small profit to start the week. Where is USD moving in the coming week, what are the different factors that will effect its move? comment and share your experience.!! Cheers
Long
by KunalGaur10
Apollo Hospitals - Management Quality and Economic MoatNSE:APOLLOHOSP Apollo Hospitals Enterprise Ltd, a prominent healthcare service provider in India, has shown significant management quality and a strong economic moat. Management Quality: Strategic Growth and Diversification: Apollo Hospitals has focused on expanding its services, including elective surgeries and diagnostics. This diversification and expansion into various healthcare segments highlight effective strategic planning. Financial Performance: The company has demonstrated robust financial growth over the years. Notably, there has been a substantial increase in net sales, EBITDA, and PAT (Profit After Tax), indicating a healthy financial status. This growth trajectory reflects strong operational capabilities and a successful business model. Operational Efficiency: The efficient operation of Apollo Hospitals is evident from the significant YoY growth in its Hospital segment and the Pharmacy business. The company has also entered into a 10-year commercial agreement with Amazon India, which is a strategic move to enhance its reach and operational efficiency. Economic Moat: Market Position and Brand Recognition: Apollo Hospitals is well-recognized in the healthcare industry, which contributes to its competitive advantage and customer loyalty. Integrated Business Model: The company's integrated business model, covering a wide range of services from primary to tertiary health requirements, strengthens its position in the healthcare sector. Operational Network: Apollo Hospitals' extensive operational network fuels its business growth, enabling it to serve a broad customer base effectively. Strengths and Weaknesses: Strengths: Strong operational performance and network. Growth initiatives that indicate potential for future expansion and development. Weaknesses: A noted decrease in working capital, which could impact business growth. Challenges such as the dearth of healthcare professionals and stringent industry regulations. In summary, Apollo Hospitals Enterprise Ltd exhibits strong management quality, marked by effective strategic planning, robust financial performance, and efficient operations. The company's economic moat is underpinned by its market position, integrated business model, and extensive operational network. While there are strengths in its operational performance and growth initiatives, the company must address issues related to working capital and navigate the challenges posed by regulatory environments and workforce management
NSE:APOLLOHOSPLong
by amitlall_79